○内原 俊記1,2 (1.新渡戸記念中野総合病院 脳神経内科・脳神経研究室, 2.東京医科歯科大学 脳神経病態学)
セッション情報
シンポジウム
[S-03] シンポジウム03 Selective vulnerability of alpha-synuclein-related neurodegeneration -beyond proteinopathy and propagation-
2021年5月19日(水) 09:50 〜 11:50 第6会場 (国立京都国際会館 2F Room B-2)
座長:Surmeier D. James(Department of Physiology, Feinberg School of Medicine, Northwestern University, IL),内原 俊記(新渡戸記念中野総合病院脳神経内科・脳神経研究室)
Misfolded alpha-synuclein (αS) is, a major component constituent of Lewy bodybodies – a common pathological feature , is tightly related to pathogenesis of Parkinson Ddisease (PD). However, Current disease-modification therapties for PD are largely focused on using antibodies to block the spread of aS pathology. But the success of this approach, which has failed in other neurodegenerative diseases, remains uncertain. One key question that is relevant to the success of this strategy is how the peculiar pattern of aS pathology seen in the PD brain arises. it is not yet clear how αS interplays with other molecules to spread itself in selected structures or neuronal groups to template PD-specific patterns of neurodegeneration. In this session, the molecule-oriented mechanisms are expandedunderlying this pattern will be explored using in the context of different systems, ranging from cellular models, novel animal models and human from human brains brains to cellular and animal models. The dDiscussion will identify what are the relevantkey molecular players in aS pathogenesis that could become future therapeutic targets to establish PD-specific strategies to tackle PDto modify PD progression
○Dalton J. Surmeier1, Fanni Geibl1, Martin Henrich1, Ted Dawson2, Wolfgang Oertel3 (1.Department of Physiology, Feinberg School of Medicine, Northwestern University, 2.Department of Neurology, Johns Hopkins School of Medicine, 3.Department of Neurology, Philipps University Marburg)
○波田野 琢, 王子 悠, 森 聡生, 服部 信孝 (順天堂大学医学部附属順天堂医院 脳神経内科)
○Ana Maria Cuervo (Institute for Aging Studies, Albert Einstein College of Medicine NY)